Guest: Kevin Strauss, MD

Guest: Chamindra Konersman, MD

Affecting one in every 10,000 births worldwide, spinal muscular atrophy, also known as SMA, can result in the progressive loss of basic muscle function and in its most severe forms, can lead to death or the need for permanent ventilation in 90% of cases by age two. How can we help ensure that patients with this debilitating disease get diagnosed early, and what role does gene therapy play in its treatment? Tune in as Dr. Chamindra Konersman from Rady Children’s Hospital in San Diego discusses that and more with Dr. Kevin Strauss from the Clinic for Special Children in Pennsylvania.

© 2021 Novartis Gene Therapies, Inc. US-ZOL-20-0544 1/2021